AASLD Program (pp. 27A-77A)

Jean Millis(Pfizer (United Kingdom)), Laurie Wi(Pfizer (United Kingdom)), B. W. Bacon(Memorial), Adrian M. Di Bisceglie, Zachary Goodman(Inova Health System), Estella M. Alonso, John R. Craig(Henry Ford Health System), Nezam H. Afdhal(Beth Israel Deaconess Medical Center), Kenneth S. Zaret(California Institute for Regenerative Medicine), Todd H. Baron(University of North Carolina at Chapel Hill), Mohamed Bishr(Purdue Pharma (Canada)), Peter R. Harris(Pfizer (United Kingdom)), William F. Balistreri(Bristol-Myers Squibb (Germany)), Jay H. Lefkowitch(Columbia College), Thomas Boyer(University of Arizona), Keith D. Lindor(University of Padua), Elizabeth M. Brunt(Washington University in St. Louis), Michael Manns(Medizinische Hochschule Hannover), Jenni Sokol(Royal Children's Hospital), Albert J. Czaja(Mayo Clinic in Arizona), Charles E. Miller(California Institute of Technology), J. H. Crawford(Langley Research Center), Omary Ronald(Purdue Pharma (Canada)), Deriiirs msrn(La Roche College), E Heathcute(Purdue Pharma (Canada)), Mitchell Skiffman(Purdue Pharma (Canada)), Sclerosing Cholangitis(Memorial), Cholangiocarcinoma Kirsteiz Boberg(Memorial), Eugene Schifi(Purdue Pharma (Canada)), Lnrcwe Porwll(Bristol-Myers Squibb (Germany)), Anthony Tazdl(Memorial), D Arid, Peter Fererici(Memorial), Michml Czap(Pfizer (United Kingdom)), William Lee(Imperial College London), Andrew Mason, John M. Belmont(La Roche College), Paul C. Watkins(Harvard University), Bruce R. Bacon(Saint Louis University), James F. Trotter(Baylor Scott & White Health), Kamal G. Ishak(Gilead Sciences (France)), Norali Terrault(La Roche College), Stephanie Wanless(Pfizer (United Kingdom)), Lawrence Friedman(Gilead Sciences (France)), Ronald J. Sokol(Children's Hospital Colorado), Emmet B. Keeffe(Stanford Medicine), Saul J. Karpen(Baylor College of Medicine)
Hepatology
October 1, 2003
Cited by 2


Related Papers